Oral ketamine for the rapid treatment of depression and anxiety in patients receiving hospice care.

Journal of Palliative Medicine
Scott A Irwin, Alana Iglewicz

Abstract

Depression is prevalent and undertreated in patients receiving hospice care. Standard antidepressants do not work rapidly or often enough to benefit most of these patients. Here, two cases are reported in which a single oral dose of ketamine provided rapid and moderately sustained symptom relief for both depression and anxiety. In addition, no adverse effects were noted. Further investigation with randomized, controlled clinical trials is necessary to firmly establish the effectiveness of oral ketamine for the treatment of depression and anxiety in patients receiving hospice care. Ketamine may be a promising safe, effective, and cost-effective rapid treatment for depression and anxiety in this population.

References

Sep 1, 1985·Psychosomatics·R J Goldberg, V Mor
Aug 1, 1983·Psychosomatic Medicine·D Spiegel, J R Bloom
May 1, 1995·Journal of Pain and Symptom Management·J L Clark, G E Kalan
Apr 16, 1999·Journal of Pain and Symptom Management·P G Fine
Feb 25, 2000·Biological Psychiatry·R M BermanJ H Krystal
Jan 5, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Mark RozansMarc J Kahn
Jan 10, 2002·Journal of Pain and Symptom Management·Thogulava R KannanAsootosh Barry
Jun 29, 2002·Anesthesia and Analgesia·Akira KudohTomoko Takazawa
Aug 7, 2003·Journal of the National Cancer Institute·Donald L PatrickUNKNOWN National Institutes of Health State-of-the-Science Panel
Jul 21, 2004·Journal of the National Cancer Institute. Monographs·Daniel L PatrickUNKNOWN National Institutes of Health State-of-the-Science Panel
Jul 24, 2004·Anesthesia and Analgesia·Kathirvel SubramaniamRichard A Steinbrook
Oct 14, 2004·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Dominique A LossignolJean-Jacques Body
Nov 29, 2005·Journal of Pain and Symptom Management·Sebastiano MercadanteSalvatore Mangione
Jan 5, 2006·The American Journal of Psychiatry·Madhukar H TrivediUNKNOWN STAR*D Study Team
Feb 3, 2006·The American Journal of Hospice & Palliative Care·Amit SoodCharles L Loprinzi
Mar 15, 2006·Pain Medicine : the Official Journal of the American Academy of Pain Medicine·Graeme E Correll, Graham E Futter
Aug 9, 2006·Archives of General Psychiatry·Carlos A ZarateHusseini K Manji
Feb 7, 2007·Journal of Pain and Symptom Management·Keith G WilsonJennifer J Clinch
May 26, 2007·Swiss Medical Weekly·John H Krystal
May 26, 2007·Swiss Medical Weekly·Michael LiebrenzRudolf Stohler
Sep 14, 2007·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Michael LiebrenzAlain Borgeat
Nov 22, 2008·Journal of Palliative Medicine·Lilianna Stefanczyk-SapiehaMichael Demas
Dec 18, 2008·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·Scott A Irwin, Frank D Ferris

❮ Previous
Next ❯

Citations

Mar 29, 2012·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Philip L JohnsonAnantha Shekhar
May 20, 2011·Journal of Palliative Medicine·Chun YangJian-jun Yang
Apr 17, 2012·Journal of Palliative Medicine·Eric E Prommer
Apr 5, 2014·Indian Journal of Psychological Medicine·Harihar ChilukuriAhammed Basha Shaik
Apr 29, 2014·Pharmacology, Biochemistry, and Behavior·Fabiana K LudkaCarla I Tasca
Dec 10, 2013·Journal of Neural Transmission·Mark J NiciuCarlos A Zarate
Feb 3, 2016·The British Journal of Psychiatry : the Journal of Mental Science·Robert A SchoeversRudie Kortekaas
Jun 4, 2013·Biological Psychiatry·John H KrystalRonald S Duman
Jun 12, 2012·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Fabiana K LudkaCarla I Tasca
Dec 3, 2010·Progress in Neuro-psychopharmacology & Biological Psychiatry·Adam StewartAllan V Kalueff
Jan 30, 2016·Current Behavioral Neuroscience Reports·Minkyung ParkCarlos A Zarate
Nov 25, 2014·CNS Neuroscience & Therapeutics·Jian Xu, Hong Lei
Sep 11, 2012·Biological Psychiatry·Sheldon H Preskorn
Jun 23, 2015·Journal of Pain and Symptom Management·Rachel QuibellAndrew Wilcock
Apr 16, 2013·Pharmacology, Biochemistry, and Behavior·Kyle S L RobinsonAllan V Kalueff
May 16, 2013·The International Journal of Neuropsychopharmacology·Benjamin D SachsMarc G Caron
May 21, 2013·The International Journal of Neuropsychopharmacology·Diogo R LaraLuciano R Munari
Dec 4, 2014·Psychiatry Research·Arpan DuttaJ F William Deakin
May 20, 2016·Current Psychiatry Reports·Faryal Mallick, Cheryl B McCullumsmith
Jul 26, 2013·ACS Chemical Neuroscience·Nikhil NeelkantanAllan V Kalueff
May 11, 2013·The Australian and New Zealand Journal of Psychiatry·Natalie KatalinicColleen K Loo
May 18, 2017·Journal of Clinical Psychopharmacology·Maryam I Al ShirawiJonathan Downar
Feb 23, 2013·Journal of Psychopharmacology·Keith G RasmussenMark A Frye
Oct 27, 2016·Expert Review of Clinical Pharmacology·Ioline D HenterRodrigo Machado-Vieira
May 9, 2015·Therapeutic Advances in Chronic Disease·Nicolas D IadarolaCarlos A Zarate
Sep 24, 2015·The Cochrane Database of Systematic Reviews·Caroline CaddyAndrea Cipriani
Feb 22, 2018·Harvard Review of Psychiatry·Ioline D HenterCarlos A Zarate
Mar 30, 2019·Journal of Palliative Medicine·Paul A RiordanJason A Webb
May 29, 2019·Journal of Pain & Palliative Care Pharmacotherapy·Christopher Richter
Nov 22, 2019·The Australian and New Zealand Journal of Psychiatry·Joshua D RosenblatAndre F Carvalho
Jan 7, 2020·Journal of Palliative Medicine·April Christensen, Jennifer Pruskowski
Jan 25, 2011·Expert Opinion on Therapeutic Targets·Kanwaljit ChopraAnurag Kuhad
Nov 2, 2018·Journal of Palliative Medicine·Jessica SextonHeather C Bruner

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.